Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: Cancer J. 2016 Sep-Oct;22(5):315–320. doi: 10.1097/PPO.0000000000000220

Figure 2.

Figure 2

Overall survival estimates by Kaplan-Meier based on each assay. Favorable and unfavorable results were dichotomized based on absent vs present detection of circulating tumor cells (CTC) by AdnaTest and direct detection RT-PCR (DDPCR) and by enumeration of <5 vs ≥5 cells/7.5 mL of blood by CellSearch assay.